Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Need to harmonize traditional and modern medicine to combat alarming health problems
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Subscribe To Our Newsletter & Stay Updated
